Back

Improved prognosis in hypertrophic cardiomyopathy over two decades - data from the Swedish national patient register

30 August 2025 (14:03 - 14:21)
Organised by: Logo
Congress Presentation Part of: Precision medicine in hypertrophic cardiomyopathy Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Jonas Silverdal

Sahlgrenska University Hospital, Gothenburg (Sweden)

3 More presentations in this session

Presentation thumbnail
State-of-the-art lecture on precision medicine in hypertrophic cardiomyopathy
Doctor C. Ho (Boston, US)
Slides Video
Presentation thumbnail
Integrated efficacy and safety analysis of mavacamten monotherapy in patients with obstructive hypertrophic cardiomyopathy
Professor I. Olivotto (Florence, IT)
Abstract Slides Video
Presentation thumbnail
Cardiovascular magnetic resonance-derived metrics as diagnostic markers for left ventricular outflow tract obstruction in hypertrophic cardiomyopathy
Mr G. Alexandridis (Rotterdam, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Precision medicine in hypertrophic cardiomyopathy
Video

The Event

Event poster

ESC Congress 2025

30 August 2025 14:03 CET
You may be interested in
thumbnail
Congress Session
Precision medicine in hypertrophic cardiomyopathy
thumbnail
Congress Presentation
Incidence and prevalence of hypertrophic cardiomyopathy in Sweden during the years 2003-2022, a nationwide observational study
thumbnail
Congress Presentation
Effectiveness of contemporary risk stratification in patients with hypertrophic cardiomyopathy: a pilot study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources